M.M. College of Pharmacy, M.M. University, Mullana-Ambala, Haryana 133207, India.
J Ethnopharmacol. 2012 Jun 26;142(1):65-71. doi: 10.1016/j.jep.2012.04.014.
In traditional Indian medicine, all parts of Emblica officinalis Gaertn plant including the fruit, seed, leaves, root, bark and flowers are used in various herbal preparations for the treatment of diabetes mellitus, chronic diarrhea, anti-inflammatory and antipyretic.
To evaluate the hypoglycemic and antioxidants effects of the hydro-methanolic (20:80) extract of leaves of Emblica officinalis Gaertn. (HMELEO) in streptozotocin induced diabetic rats.
The hypoglycemic effect was measured by blood glucose and plasma insulin level. The oxidative stress was measured in liver and kidney by level of antioxidant markers i.e. lipid peroxidation (LPO), superoxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxidase (GPx) and catalase (CAT), and the biochemical parameters, i.e. blood serum levels of creatinine, urea, serum glutamic pyruvic transaminases (SGPT), serum glutamic oxaloacetic transaminases (SGOT), alkaline phosphatase (ALP), total cholesterol and triglyceride levels were the salient features observed in diabetic control and treated rats.
Oral administration of the HMELEO at a concentration of 100, 200, 300 and 400 mg/kg b.w. daily for 45 days showed a significant (P<0.05) decrease in fasting blood glucose and increase insulin level as compared with the diabetic rats. Also it significantly (P<0.05) reduced all biochemical parameters (serum creatinine, serum urea, SGOT, SGPT and lipid profile). The treatment also resulted in a significant (P<0.05) increase in reduced glutathione, glutathione peroxidase, superoxide dismutase, catalase, and decrease LPO level in the liver and kidney of diabetic rats.
The results clearly suggest that the hydro methanolic extract of leaves of Emblica officials Gaertn. treated group may effectively normalize the impaired antioxidant status in streptozotocin induced diabetes at dose dependent manner than the glibenclamide-treated groups. The extract exerted rapid protective effects against lipid peroxidation by scavenging of free radicals and reducing the risk of diabetic complications.
在传统的印度医学中,余甘子植物的所有部分,包括果实、种子、叶子、根、树皮和花,都被用于各种草药制剂中,用于治疗糖尿病、慢性腹泻、抗炎和退热。
评估余甘子叶水-甲醇(20:80)提取物(HMELEO)对链脲佐菌素诱导的糖尿病大鼠的降血糖和抗氧化作用。
通过血糖和血浆胰岛素水平来测量降血糖作用。通过抗氧化标志物水平即脂质过氧化(LPO)、超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GPx)和过氧化氢酶(CAT),以及生化参数,即血清肌酐、尿素、血清谷氨酸丙酮酸转氨酶(SGPT)、血清谷氨酸草酰乙酸转氨酶(SGOT)、碱性磷酸酶(ALP)、总胆固醇和甘油三酯水平,来测量肝脏和肾脏的氧化应激,这些是观察到糖尿病对照组和治疗组的显著特征。
HMELEO 以 100、200、300 和 400mg/kg b.w. 的浓度每天口服给药 45 天,与糖尿病大鼠相比,可显著(P<0.05)降低空腹血糖并增加胰岛素水平。它还显著(P<0.05)降低了所有生化参数(血清肌酐、血清尿素、SGOT、SGPT 和血脂谱)。该治疗还导致糖尿病大鼠的肝和肾中的还原型谷胱甘肽、谷胱甘肽过氧化物酶、超氧化物歧化酶、过氧化氢酶增加,而脂质过氧化物水平降低。
结果清楚地表明,与格列本脲治疗组相比,余甘子叶的水-甲醇提取物在剂量依赖的方式下可有效纠正链脲佐菌素诱导的糖尿病中受损的抗氧化状态。该提取物通过清除自由基和降低糖尿病并发症的风险,迅速发挥对脂质过氧化的保护作用。